Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Emmessar Biotech & Nutrition

524768
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Emmessar Biotech & Nutrition Share price and Fundamental Analysis

View All Details
View All Details
Emmessar Biotech & Nutrition Ltd, originally started on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started with its operations manufacturing Super Specialty Fine Chemicals. In its in-house R&D, the Company succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.
Company Incorporation1992
ChairmanMSR Ayyangar
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
13.47
PE Ratio
33.68
Industry P/E
53.34
PEG Ratio
-0.8
ROE
4.1%
ROCE
11.55%
ROA
4.34%
Total Debt (Cr)
0
Debt to Equity
0
Dividend Yield
0%
EPS
0.8
Book Value & P/B
15.42 x 1.75
Face Value
10
Outstanding Shares(Cr)
0.5
Current Ratio
15.67
EV to Sales
10.47

Stock Returns

1 Week-2.51%
1 Month-5.09%
6 Months-7.45%
1 Year-27.4%
3 Years+16.7%
5 Years+110.15%
no_data

No Stocks

Smart Score

2
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Jun 25

Promoters : 59.53%

FIIs : 0.00%

DIIs : 0.20%

Public : 40.28%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in June 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Emmessar Biotech & Nutrition Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Emmessar Biotech & Nutrition Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Emmessar Biotech & Nutrition Ltd, originally started on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started with its operations manufacturing Super Specialty Fine Chemicals. In its in-house R&D, the Company succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.

On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.

ECIL's research team established that the specialty chemicals made by them had potential as 'Vital Micro Nutrients', used worldwide in research as 'tools' of Biotechnology. The Company's management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturer's and consumer's minds.

To better represent its new core activity, a change in the company's name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, became essential.

EBNL's R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the USA.

The intellectual exchange of concepts and technology between Emmessar Biotech & Nutrition Ltd., and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving a new dimension to future products emerging from the stable.

EBNL's range of products covers different aspects and unmet needs of Healthcare. They cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments.

EBNL is a Public Limited Company, with a paid-up Share Capital of about Rs. 50.00 million (over US$ 1.00 million). The Company's stocks are traded on The Bombay Stock Exchange Ltd.

Emmessar Biotech & Nutrition Share Price

Emmessar Biotech & Nutrition share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Emmessar Biotech & Nutrition Market Cap

Market capitalization of Emmessar Biotech & Nutrition indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Emmessar Biotech & Nutrition is valued compared to its competitors.

Emmessar Biotech & Nutrition PE Ratio

Emmessar Biotech & Nutrition PE ratio helps investors understand what is the market value of each stock compared to Emmessar Biotech & Nutrition 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Emmessar Biotech & Nutrition PEG Ratio

The PEG ratio of Emmessar Biotech & Nutrition evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Emmessar Biotech & Nutrition ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Emmessar Biotech & Nutrition generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Emmessar Biotech & Nutrition ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Emmessar Biotech & Nutrition in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Emmessar Biotech & Nutrition Total Debt

Total debt of Emmessar Biotech & Nutrition shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Emmessar Biotech & Nutrition Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Emmessar Biotech & Nutrition compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Emmessar Biotech & Nutrition CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Emmessar Biotech & Nutrition over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Emmessar Biotech & Nutrition Technical Analysis

Technical analysis of Emmessar Biotech & Nutrition helps investors get an insight into when they can enter or exit the stock. Key components of Emmessar Biotech & Nutrition Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Emmessar Biotech & Nutrition shares often struggle to rise above due to selling pressure.

Emmessar Biotech & Nutrition Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Emmessar Biotech & Nutrition ’s financial health and profitability.

Emmessar Biotech & Nutrition Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Emmessar Biotech & Nutrition Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Emmessar Biotech & Nutrition Financials

The financials of Emmessar Biotech & Nutrition provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Emmessar Biotech & Nutrition Profit and Loss Statements

The profit and loss statement of Emmessar Biotech & Nutrition highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Emmessar Biotech & Nutrition .

Emmessar Biotech & Nutrition Balance Sheet

The balance sheet presents a snapshot of Emmessar Biotech & Nutrition ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Emmessar Biotech & Nutrition Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.